Glenn Sobotka - 26 Mar 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Chief Accounting Officer
Signature
/s/ Glenn Sobotka
Issuer symbol
ASTH
Transactions as of
26 Mar 2025
Transactions value $
$0
Form type
4
Filing time
28 Mar 2025, 06:17:16 UTC
Previous filing
29 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Award $0 +6.43K $0.00 6.43K 26 Mar 2025 Direct F1
transaction ASTH Common Stock Award $0 +8.27K +128.56% $0.00 14.7K 26 Mar 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest in four equal annual installments beginning on March 26, 2026.
F2 Restricted a grant of performance-based restricted stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest subject to the achievement of applicable performance goals and applicable time-based conditions.
F3 Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 6,432 shares, which will vest in four equal annual installments beginning on March 26, 2026; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals.

Remarks:

Power of Attorney is attached hereto as Exhibit 24.